Secondary chromosome changes in mantle cell lymphoma

Haematologica

Volumn 84, Issue 7, 1999, Pages 594-599

  Wlodarska, Iwona ^b   Pittaluga, Stefania ^c   Hagemeijer, Anne ^a   De Wolf Peeters, Chris ^c   Van Den Berghe, Herman ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTER FOR HUMAN GENETICS   (Belgium)

^c NONE

Author keywords

Mantle cell lymphoma; Secondary abnormalities; T(11; 14)

Indexed keywords

ARTICLE; CHROMOSOME 10; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 6Q; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; MANTLE CELL LYMPHOMA;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; HUMANS; KARYOTYPING; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; TRANSLOCATION, GENETIC;

EID: 0032799060     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Weisenburger DD, Armitage JO. Mantle cell lymphoma. An entity comes of age. Blood 1996; 87:4483-94.
2. Bosch F, Jares P, Campo E, et al. PRAD1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84:2726-32.
3. Yang W, Zukerberg L, Motokura T, Arnold A, Harris N. Cyclin D1 (BCL-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994; 145:86-96.
4. de Boer CJ, Schuuring E, Dreef E, et al. Cyclin D, protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86:2715-23.
5. de Boer C, van Krieker J, Kluin-Nelemans H, Kluin P, Schuuring E. Cyclin D1 messanger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 1995; 10:1833-40.
6. Vaandrager J, Schuuring E, Zwikstra E, et al. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 1996; 88:1177-82.
7. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 1994; 13:2124-30.
8. Lovec H, Grzeschiczek A, Kowalski MB, Möröy T. Cyclin D1/bcl1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. Embo J 1994; 13:3487-95.
9. Koduru PRK, Zariwala M, Soni M, Gong JZ, Xiong Y, Broome JD. Deletion of cyclin-dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood 1995; 86:2900-5.
10. Louie DC, Offit K, Jaslow R, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892-9.
11. Greiner TC, Moynihan MJ, Chan WC, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict poor prognosis. Blood 1996; 87:4302-40.
12. Hernandez L, Fest T, Cazorla M, et al. p53 mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87:3351-9.
13. Jares P, Campo E, Pinyol M, et al. Expression of retinoblastoma gene product (pRB) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol 1996; 148:1591-600.
14. Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of P16 INK4a and P21 Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997; 89:272-80.
15. th ed. New York: Wiley-Liss; 1994.
16. ISCN. Guidelines for Cancer Cytogenetics. Mitelman F, ed. Supplement to: An International System for Human Cytogenetic Nomenclature. Basel: Karger; 1995.
17. Vandenberghe E, De Wolf-Peeters C, Van den Oord J, et al. Translocation (11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage. J Pathol 1991; 163:13-8.
18. Wlodarska I, Schoenmakers E, Kas K, et al. Molecular mapping of the chromosome 11 breakpoint of t(11;17) (q13;q21) in a t (11;14)(q13;q32)-positive B non-Hodgkin's lymphoma. Genes Chromosomes Cancer 1993; 8:224-9.
19. Pittaluga S, Wlodarska I, Stul MS, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathol 1995; 26:17-24.
20. Pittaluga S, Verhoef G, Criel A, et al. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry and cytogenetic analysis. Am J Surg Pathol 1996; 20:221-3.
21. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78:259-63.
22. Rimokh R, Berger F, Delsol G, et al. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993; 81:3063-7.
23. Ott MM, Helbing A, Ott G, et al. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol 1996; 179:238-42.
24. Johansson B, Mertens F, Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86:3905-14.
25. Nowotny H, Karlic H, Grüner H, et al. Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms. Ann Hematol 1996; 72:291-301.
26. Monni O, Oinonen R, Elonen E, et al. Genes Chromosomes Canc 1998; 21:298-307.
27. Johansson B, Mertens F, Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities - Balanced rearrangements vs. genomic imbalances? Genes Chromosomes Canc 1996; 16:155-63.
28. Liu Y, Fhermanson M, Grander D, et al. 13q deletions in lymphoid malignancies. Blood 1995; 86:1911-5.
29. Döhner H, Stilgenbauer S, James MR, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89:2516-22.
30. Larramendy ML, Siitonen SM, Zhu Y, et al. Optimized mitogen stimulation induces proliferation of neoplastic B-cell in chronic lymphocytic leukemia: significance for cytogenetic analysis. Cytogenet Cell Genet 1998; 82: 215-21.
31. Gaidano G, Hauptschein RS, Parsa NZ, et al. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma. Blood 1992; 80:1781-7.
32. Offit K, Parsa NZ, Gaidano G, et al. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82:2157-62.
33. Hayashi Y, Raimondi SC, Look AT, et al. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990; 76:1626-30.
34. Parsa NZ, Gaidano G, Mukherjee AB, et al. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines. Genes Chromosom Canc 1994; 9:13.
35. Devilder MC, François S, Bosic C, et al. Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumor suppressor gene. Cancer Res 1995; 55:1355-7.
36. Stilgenbauer S, Leupolt E, Ohl S, et al. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 1995; 55: 3475-7.
37. Stilgenbauer S, Liebisch P, James MR, et al. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 1996; 93:11837-41.
38. Stilgenbauer S, Nickolenko J, Wilhelm J, et al. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 1998; 16:1891-7.
39. Bullrich F, Veronese ML, Kitada S, et al. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 1996; 88:3109-15.
40. Gèrard B, Cavé H, Guidal C, Dastugue N, Vilmer E, Grandchamp B. Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia 1997; 11:228-32.
41. Zhang YM, Weber-Matthiesen K, Sieber TR, Matthiesen P, Schlegelberger B. Frequent deletions of 6q23-24 in B-cell non-Hodgkins lymphomas detected by fluorescence in situ hybridization. Genes Chromosomes Canc 1997; 18:310-3.
42. Argatoff L, Connors J, Klasa R, Horsman D, Gascoyne R. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997; 89:2067-78.
43. Ott G, Kalla J, Ott MM, et al. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid clones. Blood 1997; 89:1421-9.
44. Daniel M-T, Tigaud I, Flexor M-A, Nogueira, M-E, Berger R, Jonveaux P. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14) (q13;q32): a subtype of mantle cell lymphoma? Br J Haematol 1995; 90:77-84.